Kanoria Chemicals & Industries Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Kanoria Chemicals & Industries.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Chemicals earnings growth | 18.9% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Does Kanoria Chemicals & Industries (NSE:KANORICHEM) Have A Healthy Balance Sheet?
Mar 13Not Many Are Piling Into Kanoria Chemicals & Industries Limited (NSE:KANORICHEM) Just Yet
Jan 16Is Kanoria Chemicals & Industries (NSE:KANORICHEM) Using Too Much Debt?
Jul 19Returns At Kanoria Chemicals & Industries (NSE:KANORICHEM) Are On The Way Up
Dec 30Kanoria Chemicals & Industries (NSE:KANORICHEM) Has A Somewhat Strained Balance Sheet
Jul 22Does Kanoria Chemicals & Industries (NSE:KANORICHEM) Have A Healthy Balance Sheet?
Feb 16Kanoria Chemicals & Industries (NSE:KANORICHEM) Shareholders Will Want The ROCE Trajectory To Continue
Sep 18Here's Why Kanoria Chemicals & Industries (NSE:KANORICHEM) Has A Meaningful Debt Burden
Aug 23Kanoria Chemicals & Industries' (NSE:KANORICHEM) Earnings Are Of Questionable Quality
Jun 05What Do The Returns At Kanoria Chemicals & Industries (NSE:KANORICHEM) Mean Going Forward?
Mar 21What Did Kanoria Chemicals & Industries' (NSE:KANORICHEM) CEO Take Home Last Year?
Feb 14Is Kanoria Chemicals & Industries (NSE:KANORICHEM) Using Debt In A Risky Way?
Dec 31In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Kanoria Chemicals & Industries has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2024 | 14,767 | -384 | -432 | 376 | N/A |
12/31/2023 | 15,598 | -307 | N/A | N/A | N/A |
9/30/2023 | 16,032 | -238 | -314 | 327 | N/A |
6/30/2023 | 15,936 | -197 | N/A | N/A | N/A |
3/31/2023 | 15,784 | -88 | -318 | 257 | N/A |
12/31/2022 | 15,113 | 111 | N/A | N/A | N/A |
9/30/2022 | 14,497 | 15 | 184 | 740 | N/A |
6/30/2022 | 14,273 | 102 | N/A | N/A | N/A |
3/31/2022 | 13,691 | 68 | 402 | 831 | N/A |
12/31/2021 | 13,796 | 84 | N/A | N/A | N/A |
9/30/2021 | 13,822 | 425 | 479 | 811 | N/A |
6/30/2021 | 12,896 | 408 | N/A | N/A | N/A |
3/31/2021 | 10,949 | 145 | 548 | 825 | N/A |
12/31/2020 | 9,717 | -134 | N/A | N/A | N/A |
9/30/2020 | 8,800 | -405 | -75 | 185 | N/A |
6/30/2020 | 8,818 | -392 | N/A | N/A | N/A |
3/31/2020 | 10,047 | -258 | -161 | 310 | N/A |
12/31/2019 | 10,108 | -254 | N/A | N/A | N/A |
9/30/2019 | 10,404 | -333 | -820 | 235 | N/A |
6/30/2019 | 10,712 | -253 | N/A | N/A | N/A |
3/31/2019 | 10,717 | -149 | -949 | 215 | N/A |
3/31/2018 | 8,368 | 140 | -502 | 269 | N/A |
3/31/2017 | 7,020 | -148 | N/A | 300 | N/A |
3/31/2016 | 5,651 | -72 | N/A | 118 | N/A |
3/31/2015 | 5,309 | 123 | N/A | 134 | N/A |
3/31/2014 | 5,414 | 337 | N/A | 197 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if KANORICHEM's forecast earnings growth is above the savings rate (6.7%).
Earnings vs Market: Insufficient data to determine if KANORICHEM's earnings are forecast to grow faster than the Indian market
High Growth Earnings: Insufficient data to determine if KANORICHEM's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if KANORICHEM's revenue is forecast to grow faster than the Indian market.
High Growth Revenue: Insufficient data to determine if KANORICHEM's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if KANORICHEM's Return on Equity is forecast to be high in 3 years time